Understanding Your Treatment Options: Wegovy vs Mounjaro
Can You Swap From Wegovy To Mounjaro: Key Starter Considerations
When patients ask "can you swap from Wegovy to Mounjaro," the answer requires careful clinical consideration of each medication's unique characteristics. Wegovy (semaglutide) functions as a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist, representing different therapeutic approaches to weight management. The starter protocols differ significantly—Wegovy begins with 0.25mg for four weeks, followed by a structured 16-week dose escalation, whereas Mounjaro starts at 2.5mg weekly. Both are prescription-only medicines requiring clinical assessment to ensure appropriate patient selection.
Your prescriber will evaluate multiple factors when determining whether you can swap from Wegovy to Mounjaro, including your response to current treatment, side effect profile, and individual medical circumstances. The decision isn't simply about switching medications but ensuring continuity of safe, effective weight management support. EverydayMeds provides both options through our GPhC-registered pharmacy (#9012878), allowing your healthcare provider to select the most suitable treatment whilst maintaining consistent pharmaceutical care standards.
Wegovy Starter Dose Pricing and Value Proposition
The Wegovy starter journey begins with the 0.25mg dose at £79.99, representing the foundation of your 16-week dose escalation protocol. New customers can apply code FIRST40 at checkout to reach this price, whilst returning customers use DOSE25 for ongoing prescriptions. The structured pricing reflects the increasing dose strengths: 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). This transparent pricing model helps patients budget for their complete treatment pathway from initiation through maintenance phases.
For those beginning their Wegovy journey, the Intro Duo bundle (0.25mg and 0.5mg pens) provides eight weeks of treatment for £169.99, ensuring seamless progression through your initial dose escalation. The Intro Trio extends this to twelve weeks (0.25mg, 0.5mg, and 1mg) for £299.99, offering convenient supply continuity. These bundles eliminate the need for multiple orders whilst maintaining the cold-chain integrity essential for semaglutide stability throughout your starter phase.
Clinical Evidence: Understanding Why You Might Consider Swapping
When evaluating whether you can swap from Wegovy to Mounjaro, clinical trial data provides important context for prescriber decision-making. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). The SURMOUNT trials demonstrated Mounjaro's efficacy profile, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
Individual response variation means some patients may benefit from switching between treatments based on efficacy, tolerability, or lifestyle factors. Your prescriber will consider your treatment history, current progress, and any side effects when determining the most appropriate option. Both medications work through appetite regulation and satiety enhancement, though their distinct receptor mechanisms may suit different patient profiles.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones involved in appetite regulation and blood glucose control. The medication works primarily in the brain's appetite centres, reducing food cravings and promoting feelings of fullness after smaller meals. This mechanism helps patients adhere to reduced-calorie diets more effectively by addressing the physiological drivers of hunger and overeating. The once-weekly FlexTouch pen delivery system ensures consistent medication levels throughout the week, supporting steady appetite control. Understanding this mechanism helps explain why the gradual dose escalation is essential—it allows your body to adapt to the medication's effects whilst minimising potential gastrointestinal side effects.
EverydayMeds Ordering Process for Treatment Transitions
Whether you're starting Wegovy or considering if you can swap from Wegovy to Mounjaro, EverydayMeds streamlines the prescription process through our comprehensive clinical assessment system. The initial 3-minute online questionnaire captures your medical history, current medications, and treatment goals, providing prescribers with essential information for safe treatment selection. Standard prescriber review occurs within 3 working days, with express 24-hour options available for urgent requirements. Once approved, next-day delivery ensures temperature-controlled transport maintaining medication integrity from our GPhC-registered pharmacy (#9012878) to your door. This efficient process supports treatment continuity whether you're beginning therapy or transitioning between medications under prescriber guidance.
Storage and Practical Considerations for Treatment Swapping
Storage requirements represent a practical advantage when considering whether you can swap from Wegovy to Mounjaro—Wegovy maintains stability for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. Both require refrigerated storage (2-8°C) before first use, but Wegovy's extended room temperature stability offers greater flexibility for travel and lifestyle management. The FlexTouch pen system provides precise dose delivery with clear dosage windows for verification. Understanding these practical differences helps patients and prescribers select treatments that align with lifestyle requirements and ensure consistent medication adherence throughout the treatment journey.
Transitioning Between Wegovy and Mounjaro: Starter Dose Protocols
The question "can you swap from Wegovy to Mounjaro" involves understanding distinct starter protocols for each medication. Wegovy's 0.25mg starting dose represents one-tenth of the maintenance dose, requiring gradual escalation over 16 weeks to reach the target 2.4mg weekly injection. This conservative approach minimises gastrointestinal side effects whilst allowing physiological adaptation to GLP-1 receptor activation. Mounjaro begins at 2.5mg weekly, escalating to 5mg after four weeks, with potential further increases to 10mg or 15mg based on clinical response and tolerability.
Prescribers must consider washout periods and potential overlapping effects when transitioning patients between these medications. The different receptor profiles and starting doses mean switching isn't simply substituting one injection for another—it requires careful clinical planning to ensure safety and treatment continuity. EverydayMeds works with experienced prescribers who understand these complexities, ensuring any treatment transitions are managed safely with appropriate monitoring and patient education throughout the process.
Making Your Treatment Decision: Expert Guidance Available
Determining whether you can swap from Wegovy to Mounjaro requires individualised assessment considering your treatment response, lifestyle factors, and clinical goals. Both medications are available through EverydayMeds with comprehensive prescriber support to guide treatment selection and transitions. Our clinical team understands the nuances of each medication's profile, from starter dose protocols through maintenance phase management. The 3-minute clinical assessment captures relevant information for prescriber review, ensuring safe, appropriate treatment recommendations. With transparent pricing, reliable supply chains, and expert clinical oversight, EverydayMeds supports your weight management journey regardless of which treatment proves most suitable. Remember to use code FIRST40 for new customers or DOSE25 for returning patients, with next-day temperature-controlled delivery maintaining medication integrity throughout the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
